A comparative evaluation of the Instant-View 5-Panel Test Card with Ontrak Testcup Pro 5: Comparison with gas chromatography-mass spectrometry

Journal of Analytical Toxicology

Volumn 30, Issue 1, 2006, Pages 50-56

  Moody, David E ^a   Fang, Wenfang B ^a   Andrenyak, David M ^a   Monti, Kim M ^a   Jones, Chuck ^b  

^a UNIVERSITY OF UTAH   (United States)

^b Northwest Toxicology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CANNABINOID; COCAINE DERIVATIVE; OPIATE DERIVATIVE; STREET DRUG;

ARTICLE; CONTROLLED STUDY; DRUG SCREENING; EVALUATION; GAS CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; URINALYSIS; ANALYTICAL EQUIPMENT; COMPARATIVE STUDY; FORENSIC MEDICINE; HOSPITAL INFORMATION SYSTEM; IMMUNOASSAY; INSTRUMENTATION; MASS FRAGMENTOGRAPHY; METHODOLOGY; ONLINE SYSTEM; REPRODUCIBILITY; SUBSTANCE ABUSE; URINE;

FORENSIC MEDICINE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; IMMUNOASSAY; ONLINE SYSTEMS; POINT-OF-CARE SYSTEMS; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; STREET DRUGS; SUBSTANCE ABUSE DETECTION; URINALYSIS;

EID: 33646186945     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/30.1.50     Document Type: Article

References (27)

1. D.E. Moody. Immunoassays in forensic toxicology. In Encyclopedia of Analytical Chemistry, R.A. Meyers, Ed. John Wiley & Sons, Chicester, U.K., 2000, pp 4414-4447.
2. A.J. Jenkins and B.A. Goldberger. On-Site Drug Testing. Humana Press, Totowa, NJ, 2002.
3. D.J. Crouch. The OnTrak TesTcup® systems. In On-Site Drug Testing, A.J. Jenkins and B.A. Goldberger, Eds. Humana Press, Totowa, NJ, 2002, pp 163-183.
4. Package insert. OnTrak TesTcup Pro 5 collection/urinalysis panel for benzodiazepines, cocaine, methamphetamine, morphine and THC. Roche Diagnostics GmbH, Mannheim, Germany, 2001.
5. Package insert. Instant-View® multi-drug screen urine test instructions for use BZD COC MET MOR300 THC. Alfa Scientific Design Inc., Poway, CA, 2003.
6. J. Towt, S.-C.J. Tsai, M.R. Hernandez, A.D. Klimov, C.V. Kravec, S.L. Rouse, H.S. Subuhi, B. Twarowska, and S.J. Salamone. ONTRAK TESTCUP: a novel, on-site, multi-analyte screen for the detection of abused drugs. J. Anal. Toxicol. 19: 504-510 (1995).
7. D.J. Crouch, M.L. Cheever, D.M. Andrenyak, D.J. Kuntz, and D. Loughmiller. A comparison of ONTRAK TESTCUP™, Abuscreen ONTRAK™, Abuscreen ONLINE® and GC/MS urinalysis test results. J. Forensic Sci. 43: 35-40 (1998).
8. R.G. Parsons, R. Kowal, D. LeBlond, V.T. Yue, L. Neargarder, L. Bond, D. Garcia, D. Slater, and P. Rogers. Multianalyte assay system developed for drugs of abuse. Clin. Chem. 39: 1899-1903 (1993).
9. E.H. Taylor, E.H. Oertli, J.W. Wolfgang, and E. Mueller. Accuracy of five on-site immunoassay drugs-of-abuse testing devices. J. Anal. Toxicol. 23: 119-124 (1999).
10. M.R. Peace, L.D. Tarnai, and A. Poklis. Performance evaluation of four on-site drug-testing devices for detection of drugs of abuse in urine. J. Anal. Toxicol. 24: 589-594 (2000).
11. A.H.B. Wu, S.S. Wong, K.G. Johnson, J. Callies, D.X. Shu, W.E. Dunn, and S.H.Y. Wong. Evaluation of the Triage system for emergency drugs-of-abuse testing in urine. J. Anal. Toxicol. 17: 241-245 (1993).
12. J.E. Phillips, S. Bogema, P. Fu, W. Furmaga, A.H.B. Wu, V. Zic, and C. Hamment-Stabler. Signify® ER drug screen test evaluation: comparison to Triage® drug of abuse panel plus tricyclic antidepressants. Clin. Chim. Acta 328: 31-38 (2003).
13. K.F. Buechler, S. Moi, B. Noar, D. McGrath, J. Villela, M. Clancy, A. Shenhav, A. Colleymore, G. Valkirs, T. Lee, J.F. Bruni, M. Walsh, R. Hoffman, F. Ahmuty, M. Nowakowski, J. Buechler, M. Mitchell, D. Boyd, N. Stiso, and R. Anderson. Simultaneous detection of seven drugs of abuse by the Triage™ panel for drugs of abuse. Clin. Chem. 38: 1678-1684 (1992).
14. E.H. Taylor and P. Pizzo. Evaluation of DrugCheck® 9 on-site immunoassay test cup according to a standard method validation protocol. J. Anal. Toxicol. 28: 190-197 (2004).
15. T.R. Koch, R.L. Raglin, S. Kirk, and J.F. Bruni. Improved screening for benzodiazepine metabolites in urine using the Triage™ panel for drugs of abuse. J. Anal. Toxicol. 18: 168-172 (1994).
16. S. George and R.A. Braithwaite. A preliminary evaluation of five rapid detection kits for on site drugs of abuse screening. Addiction 90: 227-232 (1995).
17. A.J. Jenkins, W.D. Darwin, M.A. Huestis, E.J. Cone, and J.M. Mitchell. Validity testing of the accuPINCH™ THC test. J. Anal. Toxicol. 19: 5-12 (1995).
18. D.J. Birnbach, D.J. Stein, A. Grunebaum, B.I. Danzer, and D.M. Thys. Cocaine screening of parturients without prenatal care: an evaluation of a rapid screening assay. Anesth. Analg. 84: 76-79 (1997).
19. J.J.W. Ros, M.G. Pelders, and A.C.C. Egberts. Performance of Abusign™ drugs-of-abuse slide tests with particular emphasis on concentrations near the cutoff: comparison with FPIA-ADx and confirmation of results with GC-MS. J. Anal. Toxicol. 22: 40-44 (1998).
20. R. Wennig, M.R. Moeller, J.M. Haguenoer, A. Marocchi, F. Zoppi, B.L. Smith, R. de la Torre, C.A. Carstensen, A. Goerlach-Graw, J. Schaeffler, and R. Leinberger. Development and evaluation of immunochromatographic rapid tests for screening of cannabinoids, cocaine, and opiates in urine. J. Anal. Toxicol. 22: 148-155 (1998).
21. D.J. Crouch, J.F. Frank, L.J. Farrell, H.M. Karsch, and J.E. Klaunig. A multi-site laboratory evaluation of three on-site urinalysis drug-testing devices. J. Anal. Toxicol. 22: 493-502 (1998).
22. H.R. Kranzler, J. Stone, and L. McLaughlin. Evaluation of a point-of-care testing product for drugs of abuse: testing site is a key variable. Drug Alcohol Depend. 40: 55-62 (1995).
23. R. de la Torre, L. San, and M. Torrens. Clinical evaluation of the Triage® analytical device for drugs-of-abuse testing. Clin. Chem. 42: 1433-1438 (1996).
24. M. Gronholm and P. Lillsunde. A comparison between on-site immunoassay drug-testing devices and laboratory results. Forensic Sci. Int. 121: 37-46 (2001).
25. D.E. Moody. Drug interactions with benzodiazepines: epidemiologic correlates with other CNS depressants and in vitro correlates with inhibitors and inducers of cytochrome P450 3A4. In Handbook of Drug Interactions A Clinical and Forensic Guide , A. Mozayani and L.P. Raymon, Eds. Humana Press, Totowa, NJ, 2004, pp 3-88.
26. R.C. Baselt. Disposition of Toxic Drugs and Chemicals in Man , 5th ed. Chemical Toxicology Institute, Foster City, CA, 2000.
27. Protonix® (pantoprazole sodium): lab tests. In Physicians' Desk Reference, 59th ed. Thomson PDR, Montvale, NJ, 2005, p 3391.